Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,922 Cr
up ₹205 Cr vs Oct 2023
- Stocks held
- 26
- unchanged
- Top 10 weight
- 69.7%
- of the portfolio in its ten largest
- Cash & debt
- 2.3%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 4
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In November 2023 it disclosed 26 stocks worth ₹1,922 Cr, up ₹205 Cr from Oct 2023. Its largest positions were Sun Pharmaceutical Industries Limited (13.0%), IPCA Laboratories Limited (9.0%), Suven Pharmaceuticals Limited (8.6%); the ten largest together made up 69.7% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 73.5% of its equity. Cash and debt stood at 2.3%. Compared with Oct 2023 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
10%
Holds more stocks than 10% of peers
Cash
31%
Holds more cash than 31% of peers
What these mean: concentration · cash
Holdings in November 2023
Download CSVEvery line the fund disclosed, with the change against Oct 2023. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 12.99% | up 0.08 pts | ₹250 Cr | up ₹28 Cr | Added |
| IPCA Laboratories Limited | 8.99% | up 0.31 pts | ₹173 Cr | up ₹23.7 Cr | Added |
| Suven Pharmaceuticals Limited | 8.62% | up 0.81 pts | ₹166 Cr | up ₹31.5 Cr | Added |
| Cipla Limited | 8.10% | down 0.32 pts | ₹156 Cr | up ₹11 Cr | Added |
| Lupin Limited | 7.28% | up 0.10 pts | ₹140 Cr | up ₹16.7 Cr | Added |
| Apollo Hospitals Enterprise Limited | 5.36% | up 0.13 pts | ₹103 Cr | up ₹13.2 Cr | Added |
| Alembic Pharmaceuticals Limited | 5.22% | up 0.01 pts | ₹100 Cr | up ₹10.9 Cr | Added |
| Alkem Laboratories Limited | 4.61% | up 0.54 pts | ₹88.6 Cr | up ₹18.8 Cr | Added |
| Concord Biotech Limited | 4.34% | up 0.17 pts | ₹83.5 Cr | up ₹11.8 Cr | Added |
| Procter & Gamble Health Limited | 4.23% | down 0.48 pts | ₹81.4 Cr | up ₹42 L | Added |
| Vijaya Diagnostic Centre Limited | 3.39% | down 0.10 pts | ₹65.1 Cr | up ₹5.3 Cr | Added |
| Globus Medical Inc | 3.35% | down 0.46 pts | ₹64.4 Cr | down ₹1.1 Cr | Trimmed |
| Zydus Lifesciences Limited | 2.74% | down 0.02 pts | ₹52.7 Cr | up ₹5.3 Cr | Added |
| Intuitive Surgical Inc | 2.53% | up 0.14 pts | ₹48.6 Cr | up ₹7.6 Cr | Added |
| Indoco Remedies Limited | 2.47% | up 0.05 pts | ₹47.6 Cr | up ₹5.9 Cr | Added |
| Cash, TREPS & receivables | 2.30% | up 1.04 pts | ₹44.2 Cr | up ₹22.6 Cr | Added |
| Kovai Medical Center and Hospital Limited | 1.94% | up 0.23 pts | ₹37.3 Cr | up ₹8 Cr | Added |
| Aarti Drugs Limited | 1.87% | down 0.14 pts | ₹36 Cr | up ₹1.3 Cr | Added |
| ICICI Lombard General Insurance Company Limited | 1.86% | down 0.07 pts | ₹35.7 Cr | up ₹2.6 Cr | Added |
| Unichem Laboratories Limited | 1.57% | down 0.25 pts | ₹30.1 Cr | down ₹1 Cr | Trimmed |
| Abbott Laboratories | 1.43% | down 0.02 pts | ₹27.5 Cr | up ₹2.6 Cr | Added |
| Taro Pharmaceutical Industries Limited | 1.40% | down 0.08 pts | ₹26.8 Cr | up ₹1.5 Cr | Added |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 0.90% | up 0.04 pts | ₹17.3 Cr | up ₹2.6 Cr | Added |
| MedPlus Health Services Limited | 0.80% | down 0.09 pts | ₹15.3 Cr | up ₹11 L | Added |
| Jupiter Life Line Hospitals Limited | 0.56% | down 0.02 pts | ₹10.7 Cr | up ₹77 L | Added |
| Mankind Pharma Limited | 0.47% | down 1.51 pts | ₹9 Cr | down ₹24.9 Cr | Trimmed |
| Illumina Inc | 0.37% | down 0.07 pts | ₹7.1 Cr | down ₹52 L | Trimmed |
| Pfizer Limited | 0.32% | down 0.03 pts | ₹6.2 Cr | up ₹23 L | Added |
What changed, Oct 2023 to Nov 2023
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Suven Pharmaceuticals Limitedup ₹31.5 Cr (+0.81% pts)
- Sun Pharmaceutical Industries Limitedup ₹28 Cr (+0.08% pts)
- IPCA Laboratories Limitedup ₹23.7 Cr (+0.31% pts)
- Alkem Laboratories Limitedup ₹18.8 Cr (+0.54% pts)
- Lupin Limited ₹16.7 Cr (+0.10% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Oct 2023, the weight rose most in Healthcare Services (+0.3 pts) and Pharmaceuticals & Biotechnology (+0.2 pts), and fell most in Healthcare Equipment & Supplies (−0.3 pts) and Pharmaceuticals (−0.2 pts).
- Healthcare Services11.7% → 12.0%+0.3 pts
- Pharmaceuticals & Biotechnology73.3% → 73.5%+0.2 pts
- Healthcare Equipment & Supplies6.3% → 6.1%−0.3 pts
- Pharmaceuticals5.8% → 5.7%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Nov 2020 | Nov 2022 | May 2023 | Aug 2023 | Oct 2023 | Nov 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 63.0% | 61.2% | 71.2% | 74.6% | 73.3% | 73.5% |
| Healthcare Services | 21.9% | 23.2% | 13.3% | 11.7% | 11.7% | 12.0% |
| Healthcare Equipment & Supplies | 3.8% | 6.4% | 6.2% | 5.0% | 6.3% | 6.1% |
| Pharmaceuticals | 7.3% | 5.8% | 5.8% | 5.7% | 5.8% | 5.7% |
| Insurance | 4.0% | 2.4% | 2.3% | 2.0% | 2.0% | 1.9% |
| Retailing | — | 1.1% | 1.3% | 1.0% | 0.9% | 0.8% |
Allocation in Nov 2023change vs Oct 2023
- Pharmaceuticals & Biotechnology (14)73.5%▲ 0.2 pts
- Healthcare Services (5)12.0%▲ 0.3 pts
- Healthcare Equipment & Supplies (2)6.1%▼ 0.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Nov 2023
2.3%
▲ 1.0 pts vs Oct 2023
- Cash alone
- 2.3%
- cash and net receivables
- A year earlier
- 0.9%
- Nov 2022 · now ▲ 1.4 pts
- Last 12 months
- <0.1% – 4.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.